Mesoblast Limited (MESO)

Mesoblast Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	5.67	5.9	7.5	10.21	7.43	32.16
Revenue Growth (YoY)	-24.07%	-21.32%	-26.54%	37.35%	-76.88%	92.30%
Cost of Revenue	26.66	41.07	54.92	63.57	85.73	81.5
Gross Profit	-20.99	-35.17	-47.42	-53.36	-78.3	-49.34
Selling, General & Admin	29.33	23.63	25.37	27.21	30.87	25.61
Research & Development	0.93	-	-	-	-	-
Other Operating Expenses	0.12	-0.82	-3.51	0	-0.07	-0.08
Operating Expenses	30.38	22.8	21.87	27.21	30.8	25.53
Operating Income	-51.37	-57.97	-69.29	-80.57	-109.1	-74.87
Interest Expense	-21.15	-20.66	-19.44	-16.91	-15.94	-14.72
Interest & Investment Income	1.82	1.82	0.83	0	0.02	-
Currency Exchange Gain (Loss)	-0.87	-0.08	-0.16	-0.54	1.47	0.25
Other Non Operating Income (Expenses)	-18	-1.57	-2.88	5.51	5.23	0.61
EBT Excluding Unusual Items	-89.57	-78.45	-90.95	-92.5	-118.32	-88.74
Asset Writedown	-	-	0.08	-	-	-
Other Unusual Items	-13.66	-9.69	8.77	0.91	18.69	1.38
Pretax Income	-103.23	-88.15	-82.1	-91.59	-99.63	-87.36
Income Tax Expense	0.12	-0.19	-0.21	-0.24	-0.82	-9.42
Net Income	-103.35	-87.96	-81.89	-91.35	-98.81	-77.94
Net Income to Common	-103.35	-87.96	-81.89	-91.35	-98.81	-77.94
Shares Outstanding (Basic)	1,120	987	778	683	605	529
Shares Outstanding (Diluted)	1,120	987	778	683	605	529
Shares Change (YoY)	31.98%	26.87%	13.89%	12.86%	14.42%	6.97%
EPS (Basic)	-0.09	-0.09	-0.11	-0.13	-0.16	-0.15
EPS (Diluted)	-0.09	-0.09	-0.11	-0.13	-0.16	-0.15
Free Cash Flow	-42.72	-48.73	-63.53	-65.94	-102.4	-58.46
Free Cash Flow Per Share	-0.04	-0.05	-0.08	-0.10	-0.17	-0.11
Gross Margin	-	-	-	-	-	-153.44%
Operating Margin	-906.03%	-982.24%	-923.73%	-789.09%	-1467.53%	-232.84%
Profit Margin	-1822.77%	-1490.27%	-1091.71%	-894.59%	-1329.18%	-242.38%
Free Cash Flow Margin	-753.51%	-825.63%	-846.99%	-645.76%	-1377.40%	-181.80%
EBITDA	-49.43	-56.08	-66.84	-77.91	-106.52	-72.71
EBITDA Margin	-	-	-	-	-	-226.13%
D&A For EBITDA	1.95	1.9	2.45	2.66	2.57	2.16
EBIT	-51.37	-57.97	-69.29	-80.57	-109.1	-74.87
EBIT Margin	-	-	-	-	-	-232.84%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q